GPT and metabolic dysfunction-associated steatotic liver disease: The study of Behrouz et al. [134] investigated the use of probiotics and prebiotics in patients with NAFLD and observed reductions in AST, ALT, triglycerides, and total cholesterol but did not observe modifications in biomarkers of inflammation such as C Reactive Protein.